Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616173 · ClinicalTrials.gov registry record · Phase 4
Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block
A Phase 4 study of Fracture of Ankle, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01616173 is a Phase 4 study of Fracture of Ankle that has completed, run by Northwestern University. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01616173, a Phase 4 study of Fracture of Ankle, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients scheduled to have foot and ankle surgery will typically receive a single shot sciatic nerve block to serve as the primary anesthetic and as part of a multi-modal post-operative analgesic plan. The investigators are investigating the use of perineural dexamethasone together with local anesthetics can improve the quality of recovery for patients receiving sciatic nerve blocks for foot and ankle surgery.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Saline
Study Locations (1)
Illinois
- Northwestern University, Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01616173
The ClinicalTrials.gov registry entry for NCT01616173 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fracture of Ankle appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT01616173 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01616173 about?
NCT01616173 is a clinical study titled "Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block". Patients scheduled to have foot and ankle surgery will typically receive a single shot sciatic nerve block to serve as the primary anesthetic and as part of a multi-modal post-operative analgesic plan. The investigators are investigating the use of perineural dexamethasone together with local anesth...
What is the current status of trial NCT01616173?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2012-06. Estimated completion is 2013-06.
What conditions does trial NCT01616173 study?
This clinical trial studies the following conditions: Fracture of Ankle.
What interventions are being tested in trial NCT01616173?
The interventions under investigation include: Dexamethasone (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT01616173?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01616173 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.